Baseline characteristics of the tumor diameter <2 cm group
| Before matching | After matching | |||||||||
| LRH (n) | LRH (%) | ARH (n) | ARH (%) | Total/p value | LRH (n) | LRH (%) | ARH (n) | ARH (%) | Total/p value | |
| No | 754 | – | 1435 | – | 2189 | 739 | – | 739 | – | 1478 |
| Age (years) | 46.69±9.444 | 46.13±9.451 | 0.189 | 46.80±9.460 | 46.69±9.367 | 0.816 | ||||
| Year of surgery | <0.001 | 1.000 | ||||||||
| 2004–2009 | 25 | 3.3 | 412 | 28.7 | 25 | 3.4 | 25 | 3.4 | ||
| 2010–2016 | 729 | 96.7 | 1023 | 71.3 | 714 | 96.6 | 714 | 96.6 | ||
| Histopathology | 0.006 | 1.000 | ||||||||
| Squamous cell carcinoma | 643 | 85.3 | 1274 | 88.8 | 641 | 86.7 | 641 | 86.7 | ||
| Adenocarcinoma | 101 | 13.4 | 132 | 9.2 | 89 | 12.0 | 89 | 12.0 | ||
| Adenosquamous carcinoma | 10 | 1.30 | 29 | 2.0 | 9 | 1.2 | 9 | 1.2 | ||
| FIGO stage | 0.037 | 1.000 | ||||||||
| IA1 (LVSI+) and IA2 | 175 | 23.2 | 392 | 27.3 | 167 | 22.6 | 167 | 22.6 | ||
| IB1 | 579 | 76.8 | 1043 | 72.7 | 572 | 77.4 | 572 | 77.4 | ||
| Stromal invasion | 0.489 | 1.000 | ||||||||
| ≤1/2 | 534 | 70.8 | 1045 | 72.8 | 534 | 72.3 | 534 | 72.3 | ||
| ＞1/2 | 105 | 13.9 | 197 | 13.7 | 100 | 13.5 | 100 | 13.5 | ||
| N/A | 115 | 15.3 | 193 | 13.4 | 105 | 14.2 | 105 | 14.2 | ||
| Lymphovascular invasion | 0.060 | 1.000 | ||||||||
| Negative | 679 | 90.1 | 1326 | 92.4 | 668 | 90.4 | 668 | 90.4 | ||
| Positive | 75 | 9.9 | 109 | 7.6 | 71 | 9.6 | 71 | 9.6 | ||
| Parametrial invasion | 0.760 | 0.478 | ||||||||
| Negative | 749 | 99.3 | 1427 | 99.4 | 734 | 99.3 | 736 | 99.6 | ||
| Positive | 5 | 0.7 | 8 | 0.6 | 5 | 0.7 | 3 | 0.4 | ||
| Vaginal margin status | 0.928 | 0.256 | ||||||||
| Negative | 749 | 99.3 | 1425 | 99.3 | 734 | 99.3 | 737 | 99.7 | ||
| Positive | 5 | 0.7 | 10 | 0.7 | 5 | 0.7 | 2 | 0.3 | ||
| Lymph nodes | 0.976 | 0.435 | ||||||||
| Non-metastasis | 697 | 92.4 | 1326 | 92.4 | 686 | 92.8 | 678 | 91.7 | ||
| Metastasis | 57 | 7.6 | 109 | 7.6 | 53 | 7.2 | 61 | 8.3 | ||
| Adjuvant therapy | 0.991 | 0.293 | ||||||||
| No | 669 | 88.7 | 1273 | 88.7 | 646 | 87.4 | 659 | 89.2 | ||
| Yes | 85 | 11.3 | 162 | 11.3 | 93 | 12.6 | 80 | 10.8 | ||
ARH, abdominal radical hysterectomy; IA1, IA2, and IB1, International Federation of Gynecology and Obstetrics (FIGO) 2009 stage; LRH, laparoscopic radical hysterectomy; LVSI+, lymphovascular space invasion positive.